The long-term goal of this study is to assess the feasibility of using fetal pig pancreas fragment (FPPF) transplantation to treat patients with type I diabetes. Using the highly inbred Westran Pigs, our initial aim was to establish a rejection-free transplant model of FPPF grafted into sibling recipient pigs without immuno suppression. FPPFs were isolated from 80-100-day-old fetuses of either Westran Pigs or outbred pigs and transplanted into the thymus, spleen, liver, or kidney of the recipient Westran pig. Biopsies were taken from each transplant site at set time points and assessed histologically for islet viability, rejection, and endocrine function. Fifty-eight fetal donors were used to transplant 16 recipient pigs. A nonspecific inflammation was seen for both outbred and inbred FPPF donor tissue at day 3 and was considered a response to ischemic necrosis. However, all the transplanted outbred FPPF donor tissue was acutely rejected and lost by day 10-14. In contrast, inbred FPPF tissue showed little evidence of graft necrosis after 3 days, and growth and formation of epithelial islet cell nest-like structures were seen to 28 days after transplantation. With time after transplantation, increasing amounts of insulin immunoperoxidase staining was seen together with chromogranin and somatostatin staining. In summary, this study confirms the potential of the Westran pig to answer the unproven ability of fetal pancreatic tissue to reverse type I diabetes in a large animal model.
INTRODUCTION
Conventional treatment of type I diabetes with exoge nous insulin often fails to maintain the blood glucose levels within normal physiological levels, with conse quent development of secondary complications in the long term (20) . While glucose homeostasis can be nor malized with vascularized whole organ pancreas trans plantation, it is applicable to only a minority of patients with type I diabetes with renal failure (1, 15) . Widening the indications for pancreas transplantation will always be impractical because the cadaver donor rate will never meet the potential demand.
Transplantation of pancreatic tissue from nonhuman sources has the potential to overcome the donor short fall. Pig islet tissue has been considered to be a potential donor source of insulin-producing cells. Unfortunately, adult pig islets are difficult to isolate and primary non function is a major problem (7) . Fetal islet tissue can be isolated in large quantities (10) but its role in large ani mals is limited to a few studies that required immuno suppression for graft survival (22, 26) . Fetal pancreatic tissue can reverse diabetes in rodent models. Allogeneic fetal rodent pancreatic transplantation with well-pre served islet architecture using immunosuppression with cyclosporin A and mycophelolate mofetil has been re ported to successfully reverse streptozotocin-induced di abetes (5, 19) . Fetal pig pancreatic tissue has also been shown to survive over 5 months in immunosuppressed NOD mice (12) and in nonimmunosuppressed nude mice (11) . Furthermore, human fetal pancreas trans plants have been shown to survive for more than 2 months in nude mice with considerable growth in size of the tissue, which was insulin and glucagon positive (18, 23) .
In contrast, attempts to produce normoglycemia with allogeneic fetal pancreas tissue in large animals and al logeneic or xenogeneic tissue in the clinical setting have met with limited success (8, 24) . Additionally, the barri ers to clinical xenotransplantation have yet to be over come, and three unresolved issues exist in the allogeneic setting. They are the ability of fetal tissue to become vascularized, rejection, and the ability of the fetal tissue to mature in the adult host to the point of reversing dia betes. Despite this, few small-or large-animal studies provide continuing incentive to pursue the potential of transplantation of fetal tissue. To date, a large-animal model has not existed to evaluate the potential of fetal islet tissue to reverse diabetes in the absence of rejec tion, and the role of fetal pig pancreatic tissue has re mained uncertain.
To answer this question, we have established a col ony of small pigs (Westran pigs) that have been inbred towards the point of genetic homozygosity. These pigs are SLA identical and selected pigs within the colony are capable of accepting long-term skin grafts without immunosuppression (2) . Therefore, our hypothesis was that it should be possible to perform fetal pig pancreas fragment (FPPF) transplants between siblings and avoid rejection. This would enable us to determine if fetal pig pancreas tissue was capable of differentiating into ma ture insulin-secreting tissue and reverse diabetes in the absence of rejection and immunosuppression.
In this study inbred Westran pigs have been used to investigate technical factors that may affect the outcome of fetal pancreatic transplants, in the absence of a rejec tion response. We have examined the histological appearance of maturing inbred and outbred fetal pig pancreas fragments for the first 28 days after allotrans plantation.
MATERIALS AND METHODS

Summary
Fifty-eight fetuses were obtained from five Westran sows and four outbred sows, from which FPPFs were transplanted into a total of 16 Westran pigs. Westran pig recipients received FPPFs derived either from a repeat mating of their parents or from outbred pigs. For the former, the first litter of Westran pigs were recipients of tissue from the second litter taken from the same par ents. The outbred pig tissue acted as a control. Fetal tissue was retrieved by cesarian section at 80-100 days' gestation. Donor tissue was transplanted into the thy mus, spleen, liver, and kidney without immunosuppres sion. Biopsy and histopathology were performed at reg ular intervals after transplantation. All procedures were approved by the Westmead Hospital, Western Sydney Area Health Service Animal Care and Ethics Committee and were conducted in strict compliance with the NIH Principles of Laboratory Animal Care (16) and the guidelines of the National Health and Medical Research Council of Australia.
Operative Procedures
All operative procedures were performed under gen eral anesthetic following premedication with intramus cular 1 mg/kg ilium xylazil (Xylazine, Troy Labora tories Pty. Ltd., Sydney, Australia), 25 mg/kg tiletamine combined with 25 mg/kg zolazepam (Zoletil 100, Virbac, Australia Pty. Ltd., Sydney, Australia) and 1 mg/ kg azaperone (Stresnil, Boehringer Ingelheim Pty. Ltd., Sydney, Australia). General anesthesia was induced with 16 mg/kg IV thiopentone (Pentothal, Abbott Australasia Pty. Ltd., Sydney, Australia) and maintained with 1-2% halothane (Zeneca Ltd., Macclesfield, UK) in oxygen in halation after intubation. Pigs were recovered from anes thesia in heated pens, observed, and given analgesia, 0.01 mg/kg buprenorphine (Temgesic, Reckitt & Colman Products Ltd., Hull, UK) every 6-8 h for at least 24 h.
Retrieval of Pig FPPF
The abdomens of inbred Westran and outbred preg nant sows were prepared to provide a sterile operative field and cesarian section was performed. The maternal sow was then euthanized with IV sodium pentobarbitone (Euthal 85 mg/kg, Delta Veterinary Laboratories Pty. Ltd., Sydney, Australia). Each fetus was removed se quentially from its individual amniotic sac and euthan ized with the same agent, placed on sterile ice, and a pancreatectomy performed via a midline incision. The whole fetal pancreas was placed into a sterile container of phosphate-buffered saline (PBS, #P 4417, Sigma-Aldrich Pty. Ltd, Sydney, Australia), 5% heat-inacti vated fetal bovine serum (FBS, #15-010-0500V, Trace Biosciences Pty Ltd, Noble Park, Australia), and 100 U/ ml penicillin streptomycin (Pen/Strep, #15070-063, Life Technologies, Mulgrave, Australia).
FPPF Preparation and Culture
Fetal fragments were prepared using a modification of the method of Mandel and Koulmanda (13) . Under sterile conditions and with the aid of a dissecting micro scope, the pancreas was placed in a petri dish containing PBS with 100 U/ml Pen/Strep and 5% heat-inactivated fetal bovine serum. Extracapsular and capsular tissue was dissected free. The pancreatic tissue was microdissected into 1-mm 2 fragments using two 26-gauge nee dles mounted on 1-ml syringes. FPPFs (15) (16) (17) (18) (19) (20) (21) (22) (23) (24) (25) were placed on moistened 0.45-pm Millipore filter discs (#HVLP 04700, Millipore Pty. Ltd. Sydney, Australia), which were then placed on gelfoam (#009-0891-01-012, Pharmacia & Upjohn, Kalamazoo, MI) rafts floating on DMEM, 100 U/ml Pen/Strep, 5% FBS medium in a 90-mm-wide petri dish. The petri dishes were then placed into humidified modular incubation chambers (#6153000, ICN Biomedicals Inc., Aurora, OH) gassed with 90% O 2 /10% C0 2 (#288406G, BOC Gases, Syd ney, Australia) for at least 0.5 h before the chamber was sealed and placed in an incubator at 38°C for 3 days. The seal was then opened and the chamber allowed to equilibrate with the 10% C0 2 in the incubator for at least a further 24 h. After incubation was complete, the cham ber was removed from the incubator and the petri dishes taken out. FPPFs were carefully removed from the rafts, rinsed, and placed in tubes of 10 ml DMEM, 100 U/ml Pen/Strep, 5% FBS medium. Tissue for transplantation into one biopsy site (50 fragments) was placed in each tube. After settling to the bottom of the tube, FPPFs were aspirated into a 1-ml syringe with a 14-gauge can nula.
Viability Testing
At least two fragments from each batch of FPPFs were sampled to assess viability. The FPPFs were placed on a microscope slide and covered in 0.06 g acradine orange and 0. The biopsy site was oversewn with 3/0 poliglecaprone and digital pressure applied to achieve hemostasis. Fol lowing the first biopsy time point, the wound was closed in three layers and the pig was allowed to recover. Dur ing the second biopsy the pig was euthanized with IV sodium pentobarbitone while under general anesthesia.
Histology and Immunohistochemistry
Sections (5 pm 
RESULTS
Histological Analysis
The results of histopathologic examination are sum marized in Table 1 T lymphoblasts of the normal thymus, these cells ob scuring the grafted epithelium ( Fig. 1 A) . These lympho cytes were strongly positive for CD3, identifying their T-cell lineage (Fig. IB) In contrast, recipients of Westran FPPF had viable pancreatic ductules and islets to day 28 that were easily identified in hematoxylin and eosin-stained sections (Fig. 2) . The pancreatic nature of this tissue was con firmed by positive staining for chromogranin ( Fig. 3A) , somatostatin (Fig. 3B ), and insulin ( Fig. 3C ) in each. On every occasion, one of the three immunohistochemical stains was positive with chromagranin ( Fig. 4A ) being the most reliable and somatostatin ( Fig. 4B ) was more prominent than insulin (Fig. 4C ). The degree of fibrosis was less than was seen with transplanted outbred pig donor FPPF and the mixed inflammatory cell infiltrate less intense, with noted absence of T lymphoblasts.
Graft necrosis or epithelial cell apoptosis was seldom seen.
Histological identification of FPPF was easier from the sites under the renal capsule. There was less fibrosis than for spleen, liver, or thymus sites. Furthermore, 
DISCUSSION
Several studies have previously shown that fetal pig pancreas tissue can survive in immunosuppressed recipi ents (22, 26) . The major objective of this study was to evaluate the potential of pig fetal pancreatic tissue to numbers have yet to be found (7) . In contrast, fetal pan creatic tissue retains precursor cells with the capacity to grow and proliferate (9) and can be cultured for long periods of time without significant loss of islet tissue (14) . (6, 25) . Notwithstanding these considerations, islet-like cell nests could be readily iden tified in the Westran pig FPPF, and many showed im munohistochemical positivity for insulin, constituting at least the potential for insulin production by the trans planted FPPFs.
In summary, this study demonstrates that fetal pig pancreas fragments will survive for 28 days when allo grafted into sibs of Westran pigs without the need for immunosuppression. These results show the potential of
Westran pigs to answer the unproven ability of fetal pan creatic tissue to reverse type I diabetes in a large-animal model.
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